Research Interests
- Craniofacial surgery outcomes and quality of life
- Microsurgical techniques and flap physiology
- Skin cancer reconstruction — functional and aesthetic outcomes
- Paediatric plastic surgery — cleft, craniofacial and vascular anomalies
- Patient-reported outcome measures (PROMs) in aesthetic surgery
- Neurofibromatosis — surgical management strategies
- Executive medical leadership and healthcare quality improvement
- Evidence-based practice in aesthetic surgery
Academic Affiliations
- Honorary Senior Lecturer — Imperial College London, Faculty of Medicine
- Resident Lead for Plastic Surgery — Chelsea & Westminster Hospital NHS Foundation Trust
- Member, BAPRAS Facial Palsy Special Interest Group
- Masters in Executive Medical Leadership (EMML)
Selected Publications
- Validating a screening tool for body dysmorphic disorder in aesthetic surgery patients (2026)
- Augmented reality for teaching and training in plastic and dermatological surgery (2025)
A full list of publications is available on request, or via the PubMed, ResearchGate and Academia.edu links below. For academic enquiries or collaboration, please contact appointments@naparus.com.
Research Fellowship — Toronto
During his Microsurgical Research Fellowship at the Hospital for Sick Children and University Health Network, Toronto, Mr Naparus investigated how to prolong the viability of skeletal muscle for procedures such as face transplantation and limb replantation. His work characterised hypoxic-ischaemic and reperfusion injury in muscle, and explored pharmacological and hypoxic pre- and post-conditioning strategies to protect muscle tissue against this injury — describing, for the first time, cyclosporine as an effective pharmacological postconditioning intervention in human skeletal muscle, reducing cell death by 40% in this work. Findings were presented internationally and published in the peer-reviewed literature.
Undergraduate Research — Imperial College London
As part of his BSc in Neuroscience at Imperial College London, Mr Naparus investigated human mesenchymal stem cells, defining apoptotic pathways within these cells as part of ongoing research into protecting the newborn brain from hypoxic injury around the time of birth (perinatal hypoxic-ischaemic brain injury).